Merus Eulerpool News

Merus Aktie News

Merus wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Merus News stellen wir hier zusammen.

• 7. April ·

  SeekingAlpha
  Merus: Riding The Bispecific Wave In Oncology
• 27. März ·

  SeekingAlpha
  Franklin Biotechnology Discovery Fund Q4 2024 Commentary
• 20. Januar ·

  SeekingAlpha
  Time To Upgrade Merus N.V. To A 'Buy' After The Recent Selloff
• 17. Januar ·

  Yahoo
  Merus N.V. (MRUS): The Biotech Stock with Biggest Upside Potential
• 7. Januar ·

  Yahoo
  Jim Cramer Says Merus (MRUS) Still ‘Very Speculative’
• 17. Dezember ·

  SeekingAlpha
  Harbor Health Care ETF Q3 2024 Commentary
• 10. Dezember ·

  Yahoo
  Merus (MRUS): FDA Approval and Speculative Future in Cancer Therapy
• 7. Dezember ·

  Yahoo
  Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC
• 4. Dezember ·

  Yahoo
  Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study
• 4. Dezember ·

  Yahoo
  Merus price target lowered to $109 from $111 at Guggenheim